Pediatrics (all articles) | Page 48 of 118 | Links Medicus Content Curation & Alerts in Medicine

ADA Consensus Report: The Management of Type 1 Diabetes in Adults.

3 Oct, 2021 | 22:38h | UTC

The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) – Diabetologia

News release: New comprehensive Consensus Report to manage type 1 diabetes launched by major diabetes organisations EASD and ADA – American Associatio of Diabetes

Commentary on Twitter

What a fantastic symposium on the management of #T1D at #EASD2021! Read the full ADA–EASD consensus report here https://t.co/8cEm8N0Enr pic.twitter.com/uMj2R64CkK

— Diabetologia (@DiabetologiaJnl) October 1, 2021

Impact of COVID-19 on Pediatric Immunocompromised Patients.

1 Oct, 2021 | 10:36h | UTC

Impact of COVID-19 on Pediatric Immunocompromised Patients – Pediatric Clinics of North America

Neurological Effects of COVID-19 in Children.

1 Oct, 2021 | 10:40h | UTC

Neurological Effects of COVID-19 in Children – Pediatric Clinics of North America

RCT: Smart glasses for radial arterial catheterization in pediatric patients.

30 Sep, 2021 | 10:17h | UTC

Smart Glasses for Radial Arterial Catheterization in Pediatric Patients: A Randomized Clinical Trial – Anesthesiology

Commentary on Twitter

Via @_Anesthesiology: The use of smart glasses improved the first-attempt success rate of ultrasound-guided radial artery catheterization and reduced first-attempt procedure time and overall complication rates in pediatric patients. https://t.co/DkSXwbbcn1

— ASA® (@ASALifeline) September 28, 2021

Opinion | Data from routine Covid testing can help schools stay open this year.

29 Sep, 2021 | 10:14h | UTC

Data from routine Covid testing can help schools stay open this year – STAT

Routine COVID testing doubles detection at 3 public schools.

29 Sep, 2021 | 10:16h | UTC

Routine COVID testing doubles detection at 3 public schools – CIDRAP

Original study: Assessment of a Program for SARS-CoV-2 Screening and Environmental Monitoring in an Urban Public School District – JAMA Network Open

WHO and partners call for urgent action on meningitis – New meningitis strategy aims to save more than 200,000 lives annually.

29 Sep, 2021 | 10:06h | UTC

News release: WHO and partners call for urgent action on meningitis – New meningitis strategy aims to save more than 200,000 lives annually – World Health Organization

See guidance: Defeating meningitis by 2030: a global road map – World Health Organization

Commentaries:

WHO Launches First Global Strategy to Eliminate Bacterial Meningitis by 2030 – Health Policy Watch

LSHTM joins WHO to call for urgent action on meningitis – London School of Hygiene & Tropical Medicine

Commentary on Twitter (thread – click for more)

?! First ever global strategy to #DefeatMeningitis – a debilitating disease that kills hundreds of thousands of people each year. ?https://t.co/wG6CqmOPH1 pic.twitter.com/0q6fkTwRHm

— World Health Organization (WHO) (@WHO) September 28, 2021

Editorial: It’s time to send children back to school.

28 Sep, 2021 | 09:49h | UTC

It’s time to send children back to school – Nature Medicine

RCT: Effect of whole-genome sequencing on the clinical management of acutely ill infants with suspected genetic disease.

28 Sep, 2021 | 09:05h | UTC

Effect of Whole-Genome Sequencing on the Clinical Management of Acutely Ill Infants With Suspected Genetic Disease: A Randomized Clinical Trial – JAMA Pediatrics

Commentaries on Twitter

This @JAMAPediatrics randomized clinical trial of acutely ill infants showed that access to whole genome sequencing doubled the proportion of patients with a precision diagnosis and a change of clinical management. https://t.co/yykog2UGLT pic.twitter.com/Gd7iuuUWII

— Muin J. Khoury (@MuinJKhoury) September 27, 2021

New study found two-times more infants in the ICU get a diagnosis and precision care when they get genomes. First-line genomes may reduce healthcare disparities by providing equitable access to dx https://t.co/FOO82Mds7D pic.twitter.com/BTb5AwsVHE

— JAMA Pediatrics (@JAMAPediatrics) September 27, 2021

CDC Report: Schools without mask requirements were more likely to have Covid-19 outbreaks.

26 Sep, 2021 | 22:10h | UTC

Association Between K–12 School Mask Policies and School-Associated COVID-19 Outbreaks — Maricopa and Pima Counties, Arizona, July–August 2021 – CDC Morbidity and Mortality Weekly Report

Commentary: Schools Without Mask Requirements More Likely to See COVID-19 Outbreaks – U.S. News

Commentary on Twitter

New @CDCMMWR finds schools in two Arizona counties w/o a mask requirement were 3.5 times more likely to have a #COVID19 outbreak than schools requiring masks from the start of the school year. CDC recommends universal masking for all K–12 schools. More: https://t.co/suuuLNItxJ. pic.twitter.com/zYYqXoLH3j

— CDC (@CDCgov) September 24, 2021

Consensus Statement: Paracetamol use during pregnancy — a call for precautionary action – “Pregnant women should minimize risk by using the lowest effective APAP dose for the shortest possible time”.

26 Sep, 2021 | 22:02h | UTC

Paracetamol use during pregnancy — a call for precautionary action – Nature Reviews Endocrinology

Editorial: Caution needed: paracetamol use in pregnancy – Nature Reviews Endocrinology

Commentaries:

New research cautions about possible risks of acetaminophen use during pregnancy – STAT

Expert reaction to statement on paracetamol use during pregnancy – Science Media Centre

A Common Pain Relief Med Used in Pregnancy Should Be Taken with Caution, Experts Warn – ScienceAlert

Scientists suggest pregnant women only take paracetamol/acetaminophen if medically necessary – MedicalXpress

Commentary on Twitter

New content online: Paracetamol use during pregnancy — a call for precautionary action https://t.co/FhsB5KdRs0 pic.twitter.com/8BQUUWeTbN

— Nature Reviews Endocrinology (@NatureRevEndo) September 23, 2021

RCT confirms antibiotics are not needed for most children with uncomplicated lower respiratory tract infection if pneumonia is not suspected clinically.

24 Sep, 2021 | 09:00h | UTC

Antibiotics for lower respiratory tract infection in children presenting in primary care in England (ARTIC PC): a double-blind, randomised, placebo-controlled trial – The Lancet

Commentary on Twitter

#Antibiotic resistance is a global public health threat.

New trial indicates, unless pneumonia is suspected, clinicians should provide safety-netting advice but not prescribe antibiotics for most children presenting with chest infections. https://t.co/mOwLG5rZd1 #AMR pic.twitter.com/b0c7Z5flQk

— The Lancet (@TheLancet) September 23, 2021

Large, multinational cohort suggests ondansetron use in pregnancy does not increase the risk for adverse fetal outcomes.

24 Sep, 2021 | 08:57h | UTC

Comparison of Pregnancy Outcomes of Patients Treated With Ondansetron vs Alternative Antiemetic Medications in a Multinational, Population-Based Cohort – JAMA Network Open

Editorial: Providing Data to Empower Pregnant Patients to Make Evidence-Based Choices

Commentary on Twitter

This cohort study found there was no association between ondansetron exposure during pregnancy and increased risk of fetal death, spontaneous abortion, stillbirth, or major congenital malformations compared with exposure to other antiemetic drugs. https://t.co/hDXr72Ga01

— JAMA Network Open (@JAMANetworkOpen) April 23, 2021

European guideline on indications, performance, and clinical impact of hydrogen and methane breath tests in adult and pediatric patients.

24 Sep, 2021 | 08:54h | UTC

European guideline on indications, performance, and clinical impact of hydrogen and methane breath tests in adult and pediatric patients: European Association for Gastroenterology, Endoscopy and Nutrition, European Society of Neurogastroenterology and Motility, and European Society for Paediatric Gastroenterology Hepatology and Nutrition consensus- UEG Journal

Randomized phase 1/2 trial: Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in children and adolescents aged 3–17 years.

23 Sep, 2021 | 10:16h | UTC

Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in people younger than 18 years: a randomised, double-blind, controlled, phase 1/2 trial – The Lancet Infectious Diseases

AHA Scientific Statement: Sleep‐disordered breathing and cardiovascular disease in children and adolescents.

23 Sep, 2021 | 10:02h | UTC

Sleep‐Disordered Breathing and Cardiovascular Disease in Children and Adolescents: A Scientific Statement From the American Heart Association – Journal of the American Heart Association

News release: Obstructive sleep apnea is common in kids and may impact blood pressure, heart health – American Heart Association

[Press release – not published yet] Pfizer announces COVID-19 vaccine in children 5 to 11 years produced strong neutralizing antibody responses.

21 Sep, 2021 | 09:57h | UTC

Pfizer and BioNTech Announce Positive Topline Results From Pivotal Trial of COVID-19 Vaccine in Children 5 to 11 Years – Pfizer and BioNTech

Commentaries:

Covid-19 vaccine for 5- to 11-year-olds is safe and shows ‘robust’ antibody response, Pfizer says – CNN

Pfizer says COVID-19 vaccine safe, effective in younger children – CIDRAP

Pfizer Covid-19 vaccine generates robust antibody response in children, without serious safety issues, company says – STAT

Expert reaction to press release giving topline results from Pfizer and BioNTech from their phase 2/3 trial looking at safety and antibody responses from their COVID-19 vaccine in children aged 5 to 11 – Science Media Centre

Commentaries on Twitter

I'm so glad to see that Pfizer has data to submit for their vaccine for 5-11 year olds. But any strong assertions about safety, such as for low incidence side-effects like myocarditis, cannot made from a trial of ~1500 children.

— Eric Topol (@EricTopol) September 20, 2021

(thread – click for more)

BREAKING NEWS: Pfizer releases results of 5-11 year old trial for its vaccine. 2-dose 10 microgram regimen (Pfizer uses 30 mcg for 12 and up) administered 21 days apart (sigh, we now know we need longer duration between doses for better effectiveness)https://t.co/43MHnlZgqg

— Monica Gandhi MD, MPH (@MonicaGandhi9) September 20, 2021

(thread – click for more)

BNT-Pfizer vax trial readout (press release) for kids 5-11: it's 2 doses of 10 µg dose – a third of the size of that for 12+. They conclude it had similar results to full dose vax for the 16-25 year age group: minimal data in press release…1/3https://t.co/MgYCmWYhO2

— Hilda Bastian, PhD (@hildabast) September 20, 2021

An Update on Coronavirus Disease 2019 (COVID-19) and Pregnancy.

21 Sep, 2021 | 09:51h | UTC

An Update on Coronavirus Disease 2019 (COVID-19) and Pregnancy – American Journal of Obstetrics and Gynecology

RCT: Preemptive intervention may improve developmental outcomes in infants showing early signs of autism.

21 Sep, 2021 | 09:01h | UTC

Effect of Preemptive Intervention on Developmental Outcomes Among Infants Showing Early Signs of Autism: A Randomized Clinical Trial of Outcomes to Diagnosis – JAMA Pediatrics (free for a limited period)

Commentaries:

Intervening Before 18 Months May Reduce Odds of Autism Diagnosis in Babies Identified at High Risk – Psychiatric News Alert

Expert reaction to trial looking at the effect of a pre-emptive intervention in children showing early signs of autism on developmental outcomes – Science Media Centre

Autism therapy aimed at infants may reduce likelihood of later diagnosis – The Guardian

Commentary on Twitter

An Australian randomized clinical trial found that ‘pre-emptive’ therapy during infancy reduced #autism diagnostic behaviors and improved language ability across early childhood https://t.co/Sybbu4hRWL

— JAMA Pediatrics (@JAMAPediatrics) September 20, 2021

Review: Long COVID symptoms in children rarely persist beyond three months.

19 Sep, 2021 | 23:47h | UTC

News release: Long COVID symptoms in children rarely persist beyond three months – Murdoch Children’s Research Institute

Original study: How Common Is Long COVID in Children and Adolescents? – The Pediatric Infectious Disease Journal

Commentary: Long Covid in children and adolescents is less common than previously feared – The Guardian

Cohort study: long term follow-up showed most patients with post–COVID-19 Multisystem Inflammatory Syndrome in Children had good outcomes with no significant medium- or long-term sequelae.

Long COVID: the physical and mental health of children and non-hospitalized young people after SARS-CoV-2 infection – one in seven children may still have symptoms 15 weeks after infection.

Do kids get long COVID? And how often? A pediatrician looks at the data – Children also get Long Covid, but much less often than adults.

Illness duration and symptom profile in symptomatic school-aged children tested for SARS-CoV-2 – “Only 25 (1.8%) of 1379 children experienced symptoms for at least 56 days.”

Long-term Symptoms After SARS-CoV-2 Infection in Children and Adolescents – “This study found a low prevalence of symptoms compatible with long COVID in a randomly selected cohort of children assessed 6 months after serologic testing”.

Study shows low incidence of post-acute COVID-19 symptoms (“Long Covid”) in children after mild disease

Cohort study: Risk factors for long covid in previously hospitalized children.

M-A: More than 50 long-term effects of COVID-19.

Commentary on Twitter (thread – click for more)

#LongCOVID

We reviewed 14 studies of persisting symptoms following #COVID19 in #children & #adolescents

Most had major limitations and should be interpreted with caution.

True risk is likely to be nearer 1 in 100 than often quoted 1 in 7.#medpeds #IDTwitter

(Long) ?1/n pic.twitter.com/YL2h516sNX

— Nigel Curtis (@nigeltwitt) September 17, 2021